MatTek Corporation, Ashland, MA 01721, USA.
Altern Lab Anim. 2011 Sep;39(4):339-64. doi: 10.1177/026119291103900409.
The recently implemented 7th Amendment to the EU Cosmetics Directive and the EU REACH legislation have heightened the need for in vitro ocular test methods. To address this need, the EpiOcular(TM) eye irritation test (EpiOcular-EIT), which utilises the normal (non-transformed) human cell-based EpiOcular tissue model, has been developed. The EpiOcular-EIT prediction model is based on an initial training set of 39 liquid and 21 solid test substances and uses a single exposure period and a single cut-off in tissue viability, as determined by the MTT assay. A chemical is classified as an irritant (GHS Category 1 or 2), if the tissue viability is ≤ 60%, and as a non-irritant (GHS unclassified), if the viability is > 60%. EpiOcular-EIT results for the training set, along with results for an additional 52 substances, which included a range of alcohols, hydrocarbons, amines, esters, and ketones, discriminated between ocular irritants and non-irritants with 98.1% sensitivity, 72.9% specificity, and 84.8% accuracy. To ensure the long-term commercial viability of the assay, EpiOcular tissues produced by using three alternative cell culture inserts were evaluated in the EpiOcular-EIT with 94 chemicals. The assay results obtained with the initial insert and the three alternative inserts were very similar, as judged by correlation coefficients (r²) that ranged from 0.82 to 0.96. The EpiOcular-EIT was pre-validated in 2007/2008, and is currently involved in a formal, multi-laboratory validation study sponsored by the European Cosmetics Association (COLIPA) under the auspices of the European Centre for the Validation of Alternative Methods (ECVAM). The EpiOcular-EIT, together with EpiOcular's long history of reproducibility and proven utility for ultra-mildness testing, make EpiOcular a useful model for addressing current legislation related to animal use in the testing of potential ocular irritants.
最近实施的欧盟化妆品指令第 7 修正案和欧盟 REACH 法规提高了对体外眼刺激测试方法的需求。为了满足这一需求,开发了利用正常(非转化)人源细胞的 EpiOcular(TM)眼刺激测试(EpiOcular-EIT)。EpiOcular-EIT 预测模型基于 39 种液体和 21 种固体测试物质的初始训练集,使用单一暴露期和由 MTT 测定确定的组织活力单一截止值。如果组织活力≤60%,则化学物质被归类为刺激性(GHS 类别 1 或 2),如果活力>60%,则被归类为非刺激性(GHS 未分类)。EpiOcular-EIT 对训练集的结果,以及另外 52 种物质的结果,其中包括一系列醇、烃、胺、酯和酮,用 98.1%的灵敏度、72.9%的特异性和 84.8%的准确性区分了眼刺激性和非刺激性物质。为了确保该测试的长期商业可行性,使用三种替代细胞培养插件在 EpiOcular-EIT 中评估了 EpiOcular 组织,并使用 94 种化学物质进行了评估。通过相关系数(r²)判断,使用初始插件和三种替代插件获得的测试结果非常相似,相关系数范围为 0.82 至 0.96。EpiOcular-EIT 于 2007/2008 年进行了预验证,目前正在欧洲化妆品协会(COLIPA)的主持下,在欧洲替代方法验证中心(ECVAM)的赞助下,参与一项正式的、多实验室验证研究。EpiOcular-EIT 以及 EpiOcular 的长期重现性和在超温和测试中的实用性证明,使 EpiOcular 成为解决当前与潜在眼刺激物测试中动物使用相关的法规的有用模型。